INTRODUCTION
Interferons (IFNs) are immune mediators induced by virus infection. Type I IFNs (IFN-a and IFN-b) are strongly up-regulated by virus infection in virtually all cell types. The IFN-a subtypes are encoded by a family of clustered genes, and IFN-b by a single gene. The first discovered and best known IFN function is the establishment of an antiviral state in infected and neighboring cells. Once secreted, IFN-as and IFN-b bind to the same IFN-a/b receptor leading to the transcriptional induction of a large number of IFN-a/b stimulated genes with antiviral functions. IFN-a/bs also have broader immunoregulatory functions, and play an important role in shaping the adaptive immune response to viral pathogens. IFN-g, a cytokine important in innate and adaptive immune functioning, is the product of a single gene and signals through a distinct receptor. IFN-g is produced primarily by activated NK-and T-cells. 1, 2 In response to an acute viral infection, type I IFNs are produced by infected cells within hours, generally with a serum peak at 48 h. 3 The amount and kinetics of IFN production will also depend upon the specific viral pathogen. IFN-a/b levels fall off rapidly, but not before acting to stimulate IL-15 production and subsequent natural killer (NK) cell blastogenesis and activation. Since IFN-a/b has been found to inhibit IL-12 and IFN-g production in some settings, the large IFN-a/b-mediated expansion of the NK-cell compartment does not always lead to increased levels of IFN-g. IFN production by NK cells relies on the presence of IL-12, which is not induced by all virus infections including LCMV. In the LCMV system, the bulk of IFN-g production occurs late in infection and is secreted by the expanded, virus-specific CD8 + T cells ( Fig. 1 ). 1, 2, 4, 5 It has been well established that cytokines mediate disease and death in mice challenged with LPS. Bacterial endotoxin rapidly induces TNF-a, IL-12, and IFN-g, all of which contribute to lethality with TNF as
The phenomenon of endotoxin sensitization by virus infection is well documented but not yet well understood. Infection by virtually any viral agent will quickly induce expression of type I interferons (IFN-a/b), and type II IFN-g production will follow as NK cells and T cells are activated. It has been well established that type II IFN pretreatment can intensify the effects of endotoxin. We have recently demonstrated that type I IFN induction by lymphocytic choriomeningitis virus (LCMV) infection dramatically increases TNF-a production following LPS treatment, and that this sensitization by type I IFN is STAT1 dependent. Taken together these data suggest that the STAT1-mediated, MyD88independent, arm of the LPS signaling pathway plays an important role in endotoxin toxicity, and that this pathway mediates a major component of virus-enhanced LPS sensitization. the major mediator. IFN-g promotes increased synthesis of TNF and its receptors, while IL-12 induces further IFN-g production by NK cells. 6-8 IFN-g R -/mice, or mice treated with IFN-g neutralizing antibody, are resistant to endotoxic shock. 9, 10 In humans and experimental animals, it has long been appreciated that there is increased susceptibility to bacterial infection or endotoxin administration in virusinfected hosts, although the basis of this synergism is not clear. 11, 12 As both LPS challenge and viral infection will induce cytokine production, it is of interest to discover which of the virally induced cytokines are leading to endotoxin sensitization. In a study by Nguyen et al. 5 , mock infected and LCMV-infected animals were challenged with LPS on day 7 post-infection. The marked sensitivity of the infected animals correlated with increased serum TNF, IL-12 and IFN-g levels. Unlike studies with uninfected, LPS-challenged mice where NK cells are the primary source of IFN-g, the majority of IFN-g production by infected animals came from CD8 + T-cells. In the study described here, we have sought to determine whether IFN-a/b, the earliest response to virus infection, would also have this effect of sensitizing animals to LPS.
MATERIALS AND METHODS
C57BL6 and 129SvEv mice were obtained from Taconic Laboratories (Germantown, NY, USA). STAT1 -/mice 13 bred onto the C57BL6 or 129SvEv background, and 129SvEv mice deficient in the IFN-a/b receptor (IFNa/b R -/-), 14 the IFN-g receptor (IFN-g R -/-), or both receptors (IFN-a/b/g R -/-) were all bred at the Columbus Children's Research Institute. RAG-1 -/-(T-cell deficient) 15 and E26 (NK-and T-cell deficient mice) 16 were bred at Brown University. C57BL6 animals lacking the IFN-g ligand (IFN-g -/-) 17 were obtained from Jackson Laboratories (Bar Harbor, ME, USA). All mice were housed in specific pathogen-free conditions.
Infected mice were inoculated i.p. with 2 x 10 4 plaque forming units of the Armstrong strain of LCMV on day 0. Mice were injected i.p. with LPS from Escherichia coli strain O111:B4 (Difco, Detroit, MI, USA). Mice were sacrificed on day 2 for the harvesting of splenic and peritoneal leukocytes. Leukocytes were cultured overnight with varying dilutions of LPS. TNF-a and IFN-g concentrations were measured by ELISA.
RESULTS AND DISCUSSION
To determine whether virus-induced LPS sensitivity could be mediated by IFN-a/b as well as IFN-g, LCMVinfected mice were challenged with varying doses of LPS on day 2 after LCMV infection. As shown in Figure  1 , at this time point IFN-a secretion should be maximal and IFN-g from NK-and T-cells low. In this experiment, increased lethality was seen over the next two weeks in the infected mice receiving 50, 75, or 100 mg of LPS. This result shows that the increased LPS sensitivity can occur at early times during infection.
As TNF-a is one of the important mediators of endotoxin-mediated lethality, levels of this cytokine were measured after LPS challenge (100 mg i.p.) in the serum of uninfected controls and on day 2 after LCMV infection. TNF-a production was also was assayed after in vitro LPS treatment of splenic and peritoneal lymphocytes harvested at day 2. Increased TNF-a production was evident in the serum (5-fold increase over uninfected at 1.5 h) as well as in the leukocyte cultures (up to 6-fold increase over uninfected at 6 h). Thus increased sensitivity was found to correlate with a significant increase in TNF-a production.
Since IFN-g is known to have an important role in endotoxin-mediated morbidity and mortality, it was important to determine the role of IFN-g in virus sensitization on day 2 after LCMV infection. For this purpose, mice lacking NK-and T-cells (E26) or T-and B-cells (RAG1 -/-) were challenged with LPS on day 2 after LCMV infection, or had splenic and peritoneal leukocytes harvested for incubation with LPS in culture. Elevated levels of TNF-a were found in serum (2.0-5.9-fold over mock infected) and in splenocyte cultures (3.6-5.8-fold over mock infected) from day 2 LCMV-infected compared to uninfected mice after LPS challenge. No differences in TNF-a production 314 Durbin, Doughty, Nguyen, Caligiuri, Van Deusen, Biron were seen between wild-type and animals lacking NK-and T-, or T-and B-cells. When the same experiment was done to compare TNF-a production by LPS-treated splenocyte cultures from day 2 LCMV-infected wild-type or IFN-g -/mice, no differences were found between the mouse strains. This result indicates that virus sensitization to LPS is not mediated by IFN-g at this early time point. To ascertain whether this effect could in fact be mediated by IFN-a, uninfected mice were pretreated with recombinant IFN-a, and serum and leukocyte TNF-a levels were determined. As expected, IFN-a alone could mediate sensitization. 18 The ability of both IFN-a/b and IFN-g to sensitize for LPS toxicity may be explained by their convergent signaling pathways. Each ligand will bind to its individual receptor, but in both cases, the consequence of IFN signaling is the activation of STAT1 by tyrosine phosphorylation of residue 701 (Fig. 2) . 19 As STAT1 signaling is known to be essential for induction of a subset of TLR4induced genes by a MyD88-independent pathway, [20] [21] [22] it is likely that viral induction of IFN-a/b and the resulting STAT1 phosphorylation would enhance LPS effects.
An additional consideration is the mechanism by which IFN-b is induced by LPS signaling through Toll-like receptor 4 (TLR4). TLRs are a gene family of pattern recognition receptors, and LPS signaling is mediated by TLR4. 23 IFNa/b induction by virus depends upon phosphorylation of interferon regulatory factor 3 (IRF3) by an, as yet, unknown kinase that is somehow activated by virus infection. IRF3 activation leads to synthesis of IFN-b as well as IFN-a4 in the murine system. Upon IFN induction, the STAT1 pathway is activated by IFN-a/b binding its receptor with resulting transcriptional up-regulation of IFN-stimulated genes. Among these is IRF7, which is itself phosphorylated Fig. 3 . IFN induction and STAT1 activation by LPS. Gene induction by TLR4 depends on both MyD88-dependent and MyD88-independent pathways. LPS binding leads to transcription of the IFN-b gene by an unknown pathway ending in IRF3 phosphorylation. Phosphorylated IRF3, plus or minus other transcription factors (shown here as endotoxin induced factor or EIF), is able to activate the IFN-b promoter . Once IFN-b is synthesized and secreted, it acts through the IFN-a/b receptor to activate STAT1 and STAT2. These activated STATs, combined with the IRF9 DNA binding subunit form a complex able to bind to the IRSE promoter element found upstream of IFN-stimulated genes. IRSE binding leads to transcription of the STAT1-dependent subset of LPS stimulated genes. Not all ISRE gene regulation goes through the STAT1 pathway as pictured, direct activation of a subset of ISREs by activated IRF3 complexed with CBP/p300 has also been reported. 27 in an infected cell. Activated IRF7, in concert with IRF3, then amplifies type I IFN production by allowing transcription the remaining non-IFN-a4 subtypes. 24 While it is clear that LPS treatment directly induces IFN-b, which then activates STAT1, how this occurs is not yet understood. While IRF3 phosphorylation results from LPS treatment, the phosphorylation site is distinct from that seen in virus infection, and it is not clear whether IRF3 is able to mediate IFN-b induction in this setting. 21, 25 Once IFN-b is present, it activates STAT1 through the IFN-a/b receptor, leading to up-regulation of STAT1-dependent/LPS induced genes (Fig. 3) . It is possible that, in addition to STAT1 activation by concurrent virus infection, the presence of IRF3 phosphorylated by a virus-activated kinase may also have a role in amplifying the LPS response in the setting of virus infection.
CONCLUSIONS
It has been well established that IFN-g has an important role in virus sensitization for LPS. In the study described here, we have shown that IFN-a/b is also able to sensitize the host for endotoxin toxicity, alone or in the context of LCMV infection. Working with a series of knockout mice, we have seen that the viral effect is largely IFN-mediated, and is dependent on STAT1 activation. IFN induction and consequent STAT1 tyrosine phosphorylation are important components of the cells' response to virus infection and also the TLR4-mediated response to LPS. Taken together, it is understandable that these many shared pathways would lead to amplification of the LPS effect in a virus-infected cell.
